Obesity treatment in the UK risks becoming a two-tier system, researchers warn
Treatment for obesity in the UK could become a two-tier system where the most vulnerable patients miss out altogether.
Oct 31, 2025
1
12
Amino Acids, Peptides, and Proteins: News and Research on Glucagon-Like Peptide-1 Receptor
MeSH tree: D12.776.543.750.695.021.500
GLP-1 drugs effective for weight loss, but more independent studies needed
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform ...
Oct 29, 2025
0
28
Younger people are increasingly diagnosed with obstructive sleep apnea
Despite getting eight hours of sleep at night, Maddy Dumas struggled to stay awake during the day. If she lay down for a nap, she was out cold. It wasn't until her husband kept complaining about her loud snoring and a choking ...
Oct 27, 2025
0
14
US family health insurance hits $27,000 per year as costs soar
The cost of employer-provided health insurance has surged for a third straight year, with the annual cost of a family plan approaching $27,000, according to a new survey from the nonprofit KFF.
Oct 24, 2025
0
18
Obesity drugs regulate neural systems to curb appetite, research reveals
A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management drugs semaglutide and tirzepatide that help suppress appetite, according to findings published in ...
Oct 23, 2025
0
18
GLP-1 drugs help protect against sleep apnea, study says
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.
Oct 21, 2025
0
17
GLP-1 drugs may delay alcohol's effects in the bloodstream
There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names like Ozempic and Wegovy—could be effective in reducing alcohol use.
Oct 15, 2025
0
40
BMI shouldn't be the only way to assess who can access weight-loss drugs
About 1 in 3 Australian adults (32%) has a body-mass index (BMI) of 30 or above. A further 34% has a BMI of 25 or above.
Oct 14, 2025
0
8
Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity and its complications from ...
Oct 2, 2025
0
40
Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.
Sep 26, 2025
0
13
